Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

Irina A. Tikhonova; Tracey Jones-Hughes; James Dunham; Fiona C. Warren; Sophie Robinson; Peter Stephens; Martin Hoyle

首页> 外文期刊>PharmacoEconomics >Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

【24h】

Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

机译：校正至：奥拉押，与多柔比星组合治疗先进软组织SARCOMA：一份证据审查集团的卫生和临床研究所单一技术评估研究所的视角

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Page 41, Column 1, Section?3.1, paragraph 2, 1st sentence which

机译：Page 41，第1列，部分？3.1，第2段，第1句话

著录项

来源
《PharmacoEconomics》 |2018年第4期|共1页
作者
Irina A. Tikhonova; Tracey Jones-Hughes; James Dunham; Fiona C. Warren; Sophie Robinson; Peter Stephens; Martin Hoyle;
展开▼
作者单位

Peninsula Technology Assessment Group (PenTAG);

Peninsula Technology Assessment Group (PenTAG);

Peninsula Technology Assessment Group (PenTAG);

Peninsula Technology Assessment Group (PenTAG);

Peninsula Technology Assessment Group (PenTAG);

Royal Devon and Exeter NHS Foundation Trust;

Peninsula Technology Assessment Group (PenTAG);

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
专利

1. Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal [J] . Irina A. Tikhonova, Tracey Jones-Hughes, James Dunham, PharmacoEconomics . 2018,第4期

机译：校正至：奥拉押，与多柔比星组合治疗先进软组织SARCOMA：一份证据审查集团的卫生和临床研究所单一技术评估研究所的视角
2. Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal [J] . Tikhonova Irina A., Jones-Hughes Tracey, Dunham James, PharmacoEconomics . 2018,第1期

机译：Olaratumab与多柔比星组合治疗先进软组织SARCOMA：证据审查集团的卫生和护理学院卓越单一技术评估研究所的视角
3. Azacitidine for Treating Acute Myeloid Leukaemia with More Than 30 % Bone Marrow Blasts: An Evidence Review Group Perspective of a National Institute for Health and Care Excellence Single Technology Appraisal [J] . Tikhonova Irina A., Hoyle Martin W., Snowsill Tristan M., PharmacoEconomics . 2017,第3期

机译：亚辛酸酯用于治疗急性髓鞘白血病，骨髓爆炸超过30％：证据审查集团的卫生和护理研究所单一技术评估研究所
4. Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience [O] . Jana Käthe Striefler, Franziska Brandes, Alexander Baur, 2020

机译：Olaratumab /阿霉素联合治疗晚期或转移性软组织肉瘤-单中心经验
5. Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal [O] . Irina A. Tikhonova, Tracey Jones-Hughes, James Dunham, 2018

机译：校正至：奥拉妥押，与多柔比星组合用于治疗先进软组织萨马达：一份证据审查集团的卫生和临床卓越单一技术鉴定研究所的视角

Correction to: Olaratumab in Combination with Doxorubicin for the Treatment of Advanced Soft Tissue Sarcoma: An Evidence Review Group Perspective of a National Institute for Health and Clinical Excellence Single Technology Appraisal

摘要

著录项

相似文献

相关主题

期刊订阅